Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15401-69-1

Post Buying Request

15401-69-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15401-69-1 Usage

Uses

Berberrubine Chloride is a novel alkaloid with novel nitric-oxide donating activity. Antitumor and an antimicrobial agent.

Check Digit Verification of cas no

The CAS Registry Mumber 15401-69-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,4,0 and 1 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 15401-69:
(7*1)+(6*5)+(5*4)+(4*0)+(3*1)+(2*6)+(1*9)=81
81 % 10 = 1
So 15401-69-1 is a valid CAS Registry Number.
InChI:InChI=1/C19H17NO4/c1-22-16-3-2-11-6-15-13-8-18-17(23-10-24-18)7-12(13)4-5-20(15)9-14(11)19(16)21/h2-3,6-9,15,21H,4-5,10H2,1H3

15401-69-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name BERBERRUBINE, HYDROCHLORIDE, DIHYDRATE

1.2 Other means of identification

Product number -
Other names Chileninone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15401-69-1 SDS

15401-69-1Synthetic route

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water at 20℃; for 8h;98%
With hydrogenchloride In chloroform Ambient temperature;94.1%
With hydrogenchloride In ethanol; water pH=5 - 6;82%
With hydrogenchloride In water
With hydrogenchloride In ethanol at 20℃;
berberine chloride
633-65-8

berberine chloride

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
at 180℃; for 0.333333h;98%
In N,N-dimethyl-formamide at 160℃;94%
at 190℃; for 0.333333h;93.92%
berberrubine
17388-19-1

berberrubine

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
With hydrogenchloride In water; acetonitrile at 20℃; for 3h;90%
berberine chloride hydrate
68030-18-2

berberine chloride hydrate

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
at 190℃; under 20 - 30 Torr; for 2h; Calcination;80%
9-O-(2,4-dinitrobenzenesulfonyl)berberrubine

9-O-(2,4-dinitrobenzenesulfonyl)berberrubine

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
With sulfide ion In aq. buffer pH=7.2;
C19H16NO4(1+)*HO(1-)

C19H16NO4(1+)*HO(1-)

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
With hydrogenchloride In water Cooling;
With hydrogenchloride In water
3-methoxy-2-hydroxybenzaldehyde
148-53-8

3-methoxy-2-hydroxybenzaldehyde

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
3.1: hydrogenchloride / water / Cooling
3.2: 2 h / 85 - 120 °C
3.3: 0.67 h / 85 - 90 °C
4.1: hydrogenchloride / water / Cooling
View Scheme
Multi-step reaction with 4 steps
1.1: 70 - 95 °C / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
3.1: hydrogenchloride / water / 70 - 90 °C
3.2: 2 h / 85 - 120 °C
3.3: 85 °C
4.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 4 steps
1.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
3.1: hydrogenchloride / 20 °C
4.1: copper dichloride / 2 h / 85 - 120 °C
4.2: 0.67 h / 85 °C
View Scheme
3,4-methylenedioxyphenylethylamine
1484-85-1

3,4-methylenedioxyphenylethylamine

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
3.1: hydrogenchloride / water / Cooling
3.2: 2 h / 85 - 120 °C
3.3: 0.67 h / 85 - 90 °C
4.1: hydrogenchloride / water / Cooling
View Scheme
Multi-step reaction with 4 steps
1.1: 70 - 95 °C / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
3.1: hydrogenchloride / water / 70 - 90 °C
3.2: 2 h / 85 - 120 °C
3.3: 85 °C
4.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 4 steps
1.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
2.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
3.1: hydrogenchloride / 20 °C
4.1: copper dichloride / 2 h / 85 - 120 °C
4.2: 0.67 h / 85 °C
View Scheme
2-{[(E)-2-Benzo[1,3]dioxol-5-yl-ethylimino]-methyl}-6-methoxy-phenol
880344-81-0

2-{[(E)-2-Benzo[1,3]dioxol-5-yl-ethylimino]-methyl}-6-methoxy-phenol

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
2.1: hydrogenchloride / water / Cooling
2.2: 2 h / 85 - 120 °C
2.3: 0.67 h / 85 - 90 °C
3.1: hydrogenchloride / water / Cooling
View Scheme
Multi-step reaction with 3 steps
1.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
2.1: hydrogenchloride / water / 70 - 90 °C
2.2: 2 h / 85 - 120 °C
2.3: 85 °C
3.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 3 steps
1.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
2.1: hydrogenchloride / 20 °C
3.1: copper dichloride / 2 h / 85 - 120 °C
3.2: 0.67 h / 85 °C
View Scheme
Methylenedioxybenzene
274-09-9

Methylenedioxybenzene

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: ethyl acetate / 8 h
2.1: 70 - 95 °C / Autoclave
3.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
4.1: hydrogenchloride / water / 70 - 90 °C
4.2: 2 h / 85 - 120 °C
4.3: 85 °C
5.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 5 steps
1.1: ethyl acetate / 8 h
2.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
3.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
4.1: hydrogenchloride / 20 °C
5.1: copper dichloride / 2 h / 85 - 120 °C
5.2: 0.67 h / 85 °C
View Scheme
2-methoxy-phenol
90-05-1

2-methoxy-phenol

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1.1: triethylamine / acetonitrile / 1 h / 65 °C / Reflux
2.1: 70 - 95 °C / Autoclave
3.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
4.1: hydrogenchloride / water / 70 - 90 °C
4.2: 2 h / 85 - 120 °C
4.3: 85 °C
5.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 5 steps
1.1: triethylamine / acetonitrile / 65 °C / Reflux; Acidic conditions
2.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
3.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
4.1: hydrogenchloride / 20 °C
5.1: copper dichloride / 2 h / 85 - 120 °C
5.2: 0.67 h / 85 °C
View Scheme
benzene-1,2-diol
120-80-9

benzene-1,2-diol

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: sodium hydroxide; methanol; magnesium chloride / 3 h / 65 °C
2.1: triethylamine / acetonitrile / 1 h / 65 °C / Reflux
3.1: 70 - 95 °C / Autoclave
4.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
5.1: hydrogenchloride / water / 70 - 90 °C
5.2: 2 h / 85 - 120 °C
5.3: 85 °C
6.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 6 steps
1.1: dimethyl sulfoxide / 6 h / 130 °C / Alkaline conditions
2.1: ethyl acetate / 8 h
3.1: 70 - 95 °C / Autoclave
4.1: hydrogen / 0.83 h / 70 - 115 °C / Autoclave; High pressure
5.1: hydrogenchloride / water / 70 - 90 °C
5.2: 2 h / 85 - 120 °C
5.3: 85 °C
6.1: hydrogenchloride / water
View Scheme
Multi-step reaction with 6 steps
1.1: dimethyl sulfoxide / 6 h / 130 °C / Alkaline conditions
2.1: ethyl acetate / 8 h
3.1: 0.5 h / 70 - 95 °C / 712.57 Torr / Autoclave
4.1: hydrogen / 0.83 h / 70 - 115 °C / 22502.3 - 30003 Torr / Autoclave
5.1: hydrogenchloride / 20 °C
6.1: copper dichloride / 2 h / 85 - 120 °C
6.2: 0.67 h / 85 °C
View Scheme
C17H19NO4*ClH

C17H19NO4*ClH

acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

berberrubine chloride
15401-69-1

berberrubine chloride

Conditions
ConditionsYield
Stage #1: C17H19NO4*ClH; acetic anhydride; acetic acid With copper dichloride at 85 - 120℃; for 2h;
Stage #2: With ammonium hydroxide at 85℃; for 0.666667h;
Stage #3: With hydrogenchloride
berberrubine chloride
15401-69-1

berberrubine chloride

propargyl bromide
106-96-7

propargyl bromide

9-o-(propynyl)berberine hydrochloride

9-o-(propynyl)berberine hydrochloride

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 80℃; Inert atmosphere;100%
In acetonitrile at 70 - 80℃; for 2.5h;0.35 g
In N,N-dimethyl-formamide at 20 - 80℃; for 8h;3.83 g
berberrubine chloride
15401-69-1

berberrubine chloride

acetic acid
64-19-7

acetic acid

2-(3,5-difluorophenyl)acetaldehyde
109346-94-3

2-(3,5-difluorophenyl)acetaldehyde

C27H20F2NO4(1+)*C2H3O2(1-)

C27H20F2NO4(1+)*C2H3O2(1-)

Conditions
ConditionsYield
at 115℃; for 8h;98%
berberrubine chloride
15401-69-1

berberrubine chloride

1-Adamantanecarbonyl chloride
2094-72-6

1-Adamantanecarbonyl chloride

9-O-(1-adamantoyl)berberrubine chloride
1297302-92-1

9-O-(1-adamantoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;96%
berberrubine chloride
15401-69-1

berberrubine chloride

2-fluoro-4-(trifluoromethyl)benzoyl chloride
126917-10-0

2-fluoro-4-(trifluoromethyl)benzoyl chloride

9-O-(2-flouro-4-triflouromethylbenzoyl)berberrubine chloride
1297302-84-1

9-O-(2-flouro-4-triflouromethylbenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;96%
berberrubine chloride
15401-69-1

berberrubine chloride

4-methoxy-benzoyl chloride
100-07-2

4-methoxy-benzoyl chloride

9-O-(4-methoxybenzoyl)berberrubine chloride
1297302-68-1

9-O-(4-methoxybenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;96%
berberrubine chloride
15401-69-1

berberrubine chloride

2-naphthaloyl chloride
2243-83-6

2-naphthaloyl chloride

9-O-(2-naphthoyl)berberrubine chloride
1297302-62-5

9-O-(2-naphthoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;96%
2-Thiophenecarbonyl chloride
5271-67-0

2-Thiophenecarbonyl chloride

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(2-thiopheneoyl)berberrubine chloride
1297302-76-1

9-O-(2-thiopheneoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;95%
3,4-(methylenedioxy)benzoyl chloride
25054-53-9

3,4-(methylenedioxy)benzoyl chloride

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(piperonyl)berberrubine chloride
1297302-72-7

9-O-(piperonyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;95%
berberrubine chloride
15401-69-1

berberrubine chloride

2-fluoro-6-(trifluoromethyl)benzoyl chloride

2-fluoro-6-(trifluoromethyl)benzoyl chloride

9-O-(2-flouro-6-triflouromethylbenzoyl)berberrubine chloride
1297302-90-9

9-O-(2-flouro-6-triflouromethylbenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;95%
berberrubine chloride
15401-69-1

berberrubine chloride

2-trifluoromethyl-4-fluorobenzoyl chloride
189807-21-4

2-trifluoromethyl-4-fluorobenzoyl chloride

9-O-(4-flouro-2-triflouromethylbenzoyl)berberrubine chloride
1297302-86-3

9-O-(4-flouro-2-triflouromethylbenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;95%
berberrubine chloride
15401-69-1

berberrubine chloride

benzoyl chloride
98-88-4

benzoyl chloride

2,3-methenedioxy-9-benzoxy-10-methoxyprotoberberine chloride

2,3-methenedioxy-9-benzoxy-10-methoxyprotoberberine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;94%
With pyridine In acetonitrile at 20℃;51.2%
With pyridine In chloroform for 2h; Heating / reflux;
With pyridine In chloroform for 2h; Reflux;
With pyridine In acetonitrile at 50 - 60℃;
2-thienylacetic acid chloride
39098-97-0

2-thienylacetic acid chloride

berberrubine chloride
15401-69-1

berberrubine chloride

C25H20NO5S(1+)*Cl(1-)
1297302-78-3

C25H20NO5S(1+)*Cl(1-)

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;94%
berberrubine chloride
15401-69-1

berberrubine chloride

3,4-difluorobenzoyl chloride
76903-88-3

3,4-difluorobenzoyl chloride

9-O-(3,4-diflourobenzoyl)berberrubine chloride
1297302-82-9

9-O-(3,4-diflourobenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;94%
berberrubine chloride
15401-69-1

berberrubine chloride

benzoic acid
65-85-0

benzoic acid

2,3-methenedioxy-9-benzoxy-10-methoxyprotoberberine chloride

2,3-methenedioxy-9-benzoxy-10-methoxyprotoberberine chloride

Conditions
ConditionsYield
Stage #1: berberrubine chloride With dicyclohexyl-carbodiimide In N,N-dimethyl-formamide for 0.25h;
Stage #2: benzoic acid With dmap In N,N-dimethyl-formamide at 60℃; for 1.5h; Temperature; Solvent;
93.4%
2-furancarbonyl chloride
527-69-5

2-furancarbonyl chloride

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(2-furoyl)berberrubine chloride
1297302-74-9

9-O-(2-furoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;93%
4-fluoro-3-trifluoromethylbenzoyl chloride
67515-56-4

4-fluoro-3-trifluoromethylbenzoyl chloride

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(4-flouro-3-triflouromethylbenzoyl)berberrubine chloride
1297302-88-5

9-O-(4-flouro-3-triflouromethylbenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;93%
berberrubine chloride
15401-69-1

berberrubine chloride

2,4-difluorobenzoyl chloride
72482-64-5

2,4-difluorobenzoyl chloride

9-O-(2,4-diflourobenzoyl)berberrubine chloride
1297302-80-7

9-O-(2,4-diflourobenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;93%
1,4-dibromo-butane
110-52-1

1,4-dibromo-butane

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(4-bromoethane)berberine hydrochloride

9-O-(4-bromoethane)berberine hydrochloride

Conditions
ConditionsYield
In acetonitrile at 85 - 90℃; for 1h;92%
In N,N-dimethyl-formamide at 80℃; for 2h;80%
In N,N-dimethyl-formamide at 80℃; for 10h; Solvent; Temperature; Reflux;
In N,N-dimethyl-formamide at 50℃; for 10h;
4-(methylthio)benzoyl chloride
1442-06-4

4-(methylthio)benzoyl chloride

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-(4-methylthiobenzoyl)berberrubine chloride
1297302-70-5

9-O-(4-methylthiobenzoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;92%
berberrubine chloride
15401-69-1

berberrubine chloride

naphthalene-1-carbonic acid chloride
879-18-5

naphthalene-1-carbonic acid chloride

9-O-(1-naphthoyl)berberrubine chloride
1297302-65-8

9-O-(1-naphthoyl)berberrubine chloride

Conditions
ConditionsYield
In acetonitrile at 20℃; for 0.5h;92%
berberrubine chloride
15401-69-1

berberrubine chloride

3,4-dichlorobenzyl bromide
18880-04-1

3,4-dichlorobenzyl bromide

9-O-(3,4-dichlorobenzyl)berberine bromide

9-O-(3,4-dichlorobenzyl)berberine bromide

Conditions
ConditionsYield
Stage #1: berberrubine chloride With potassium carbonate In acetonitrile at 80℃; for 0.5h;
Stage #2: 3,4-dichlorobenzyl bromide In acetonitrile at 80℃; for 1h;
91%
berberrubine chloride
15401-69-1

berberrubine chloride

propyl bromide
106-94-5

propyl bromide

10-methoxy-9-propoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium; chloride

10-methoxy-9-propoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium; chloride

Conditions
ConditionsYield
In acetonitrile for 6h; Reflux;91%
1-bromo-hexane
111-25-1

1-bromo-hexane

berberrubine chloride
15401-69-1

berberrubine chloride

9-O-hexanyl berberine chloride

9-O-hexanyl berberine chloride

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 3h;89%
With potassium carbonate In acetonitrile Inert atmosphere; Reflux;69%
berberrubine chloride
15401-69-1

berberrubine chloride

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

2,3-methylenedioxy-9-ethyloxyformyloxy-10-methoxyprotoberberine chloride

2,3-methylenedioxy-9-ethyloxyformyloxy-10-methoxyprotoberberine chloride

Conditions
ConditionsYield
With triethylamine In dichloromethane for 0.5h;88%
With potassium carbonate In acetonitrile at 70℃;37%
With pyridine In acetonitrile at 50 - 60℃;
berberrubine chloride
15401-69-1

berberrubine chloride

acetic anhydride
108-24-7

acetic anhydride

9-Acetyl, 9-demethylberberine chloride
2464-76-8

9-Acetyl, 9-demethylberberine chloride

Conditions
ConditionsYield
With pyridine at 20℃;88%
berberrubine chloride
15401-69-1

berberrubine chloride

p-Methoxybenzyl bromide
2746-25-0

p-Methoxybenzyl bromide

9-O-(4-methoxybenzyl)berberine bromide

9-O-(4-methoxybenzyl)berberine bromide

Conditions
ConditionsYield
Stage #1: berberrubine chloride With potassium carbonate In acetonitrile at 80℃; for 0.5h;
Stage #2: p-Methoxybenzyl bromide In acetonitrile at 80℃; for 1h;
88%
berberrubine chloride
15401-69-1

berberrubine chloride

4-Nitrobenzenesulfonyl chloride
98-74-8

4-Nitrobenzenesulfonyl chloride

2,3-methylenedioxy-9-((p-nitrophenylsulfonyl)oxy)-10-methoxyprotoberberine chloride
1095272-04-0

2,3-methylenedioxy-9-((p-nitrophenylsulfonyl)oxy)-10-methoxyprotoberberine chloride

Conditions
ConditionsYield
In chloroform for 7h;87.7%
With triethylamine In acetonitrile at 70℃;31%
In chloroform at 70℃; for 7h;
In chloroform at 70℃; for 7h;

15401-69-1Downstream Products

15401-69-1Related news

High fat diet aggravates the nephrotoxicity of berberrubine (cas 15401-69-1) by influencing on its pharmacokinetic profile08/15/2019

Berberrubine (BRB), the active metabolite of berberine (BBR), possesses various pharmacological activities. In this study, we found BRB showed not only a stronger lipid-lowering effect than berberine but also a specific nephrotoxicity in mice fed with high fat diet (HFD). To explore the underlyi...detailed

Resonance driven regioselective demethylation of berberine. Microwave assisted synthesis of berberrubine (cas 15401-69-1) and its assessment as fluorescent chemosensor for alkanes08/14/2019

Berberrubine has been synthesized by microwave assisted selective demethylation of berberine. The high selectivity observed in this reaction has been explained and justified by means of computational calculations using Density Functional Theory (DFT) and Natural Resonance Theory (NRT). The exist...detailed

Pharmacokinetics in rats and tissue distribution in mouse of berberrubine (cas 15401-69-1) by UPLC-MS/MS08/13/2019

Berberrubine is an isoquinoline alkaloid isolated from Berberis vulgaris L, and it is readily derived from berberine. In this study, a sensitive and selective ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the determination of berberrubine in rat plasma ...detailed

Identification of berberrubine (cas 15401-69-1) metabolites in rats by using ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry08/12/2019

Berberrubine, an isoquinoline alkaloid isolated from many medicinal plants, possesses diverse pharmacological activities, including glucose-lowering, lipid-lowering, anti-inflammatory, and anti-tumor effects. This study aimed to investigate the metabolic profile of berberrubine in vivo. Therefor...detailed

15401-69-1Relevant articles and documents

Synthesis of Mannich base derivatives of berberine and evaluation of their anticancer and antioxidant effects

Mistry, Bhupendra,Patel, Rahul V.,Keum, Young Soo,Noorzai, Rafi,Gansukh, Enkhtaivan,Kim, Doo Hwan

, p. 73 - 77 (2016)

The 9-demethylated derivative of the isoquinoline alkaloid berberine was derivatised in its isoquinoline moiety using enamines derived from formaldehyde and morpholine, piperidine, carbazole and six variously substituted piperazines to form Mannich base products which were evaluated for their in vitro biological effects. Standard tests determined their radical scavenging potential and their ferric reducing antioxidant power (FRAP). Cancerous growth inhibitory efficacies were assessed using cervical cancer cell lines HeLa and CaSki and their cytotoxicities towards normal cell lines were evaluated using Madin-Darby canine kidney (MDCK) cell lines. Piperazine derivatives bearing a heterocyclic nitrogen substituent such as a pyridyl or a pyrimidyl ring were the most active antioxidant and anticancer agents. A carbazole moiety attached to the berberine core also demonstrated excellent inhibitory effects on cancerous cells.

Synthesis of berberine-piperazine conjugates as potential antioxidant and cytotoxic agents

Mistry, Bhupendra,Keum, Young Soo,Pandurangan, Muthuraman,Patel, Rahul V.,Kim, Doo Hwan

, p. 2461 - 2470 (2016)

Piperazine derivatives bearing different electron-withdrawing and electron-donating functional groups were linked to the well-known isoquinoline alkaloid derivative, berberine via efficient organic transformations. The entire target berberine-based analogues were examined for their in vitro antioxidant potency using 2,2-diphenyl-1-picrylhydrazyl and 2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid bioassays, and anticancer activities using sulforhodamine B assay against HeLa and CaSki cervical cancer cell lines in addition to the cytotoxicity using Madin-Darby canine kidney non-cancer cell lines and, ascorbic acid and berberine used as a control for antioxidant and anticancer activities, respectively. Bioassay results revealed that newer compounds were more active against CaSki and HeLa cell lines with therapeutic indices better than that of parent berberine and showed tolerable cytotoxicity to the normal cells. A final analogue 5a with 4-methylpiperazine substituent indicated most significant anticancer potency with a therapeutic index of 58.53 (HeLa) and 48.76 (CaSki), followed by those bearing meta-chloropiperazine rings with a therapeutic index of 41.83 (HeLa) and 47.35 (CaSki), respectively.In addition, newly synthesized analogues exerted a significant radical scavenging activity against 2,2′-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid cation with IC50 values of 8.917 μg/mL, and were good to moderate scavengers of 2,2-diphenyl-1-picrylhydrazyl radical with IC50 values of 25.40 μg/mL. Synthesized compound was characterized using several techniques, fourier transform infrared spectroscopy, 1H nuclear magnetic resonance, 13C nuclear magnetic resonance, mass spectroscopy and elemental (CHN) analyses.

Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects

Spinozzi, Silvia,Colliva, Carolina,Camborata, Cecilia,Roberti, Marinella,Ianni, Cristina,Neri, Flavia,Calvarese, Claudio,Lisotti, Andrea,Mazzella, Giuseppe,Roda, Aldo

, p. 766 - 772 (2014)

Berberine (1) is an alkaloid used widely in the treatment of several diseases. However, its physicochemical properties, pharmacokinetics, and metabolism remain unclear, and conflicting data have been reported. In this study, the main physicochemical properties of 1 and its metabolites were evaluated, including lipophilicity, solubility, pKa, and albumin binding. A sensitive HPLC-ESIMS/MS method was developed and validated to identify 1 and its main metabolites in human plasma. This method was used to quantify their levels in the plasma of healthy volunteers and hypercholesterolemic patients following a single dose and chronic administration, respectively. In both cases, berberrubine (2) was found to be the main metabolite. Surprisingly, 2 is more lipophilic than 1, which suggests that this compound tautomerizes to a highly conjugated, electroneutral quinoid structure. This was confirmed by NMR studies. These results indicate that the higher plasma concentration of 2 was a consequence of a more efficient intestinal absorption, suggesting that berberrubine is potentially more pharmacologically active than berberine.

Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii

Gao, Wei-Wei,Gopala, Lavanya,Bheemanaboina, Rammohan R. Yadav,Zhang, Guo-Biao,Li, Shuo,Zhou, Cheng-He

, p. 15 - 37 (2018)

Aminothiazolyl berberine derivatives as potentially antimicrobial agents were designed and synthesized in an effort to overcome drug resistance. The antimicrobial assay revealed that some target compounds exhibited significantly inhibitory efficiencies toward bacteria and fungi including drug-resistant pathogens, and the aminothiazole and Schiff base moieties were helpful structural fragments for aqueous solubility and antibacterial activity. Especially, aminothiazolyl 9-hexyl berberine 9c and 2,4-dichlorobenzyl derivative 18a exhibited good activities (MIC = 2 nmol/mL) against clinically drug-resistant Gram-negative Acinetobacter baumanii with low cytotoxicity to hepatocyte LO2 cells, rapidly bactericidal effects and quite slow development of bacterial resistance toward A. baumanii. Molecular modeling indicated that compounds 9c and 18a could bind with GLY-102, ARG-136 and/or ALA-100 residues of DNA gyrase through hydrogen bonds. It was found that compounds 9c and 18a were able to disturb the drug-resistant A. baumanii membrane effectively, and molecule 9c could not only intercalate but also cleave bacterial DNA isolated from resistant A. baumanii, which might be the preliminary antibacterial action mechanism of inhibiting the growth of A. baumanii strain. In particular, the combination use of compound 9c with norfloxacin could enhance the antibacterial activity, broaden antibacterial spectrum and overcome the drug resistance.

Discovery of natural berberine-derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli

Zhang, Guo-Biao,Maddili, Swetha Kameswari,Tangadanchu, Vijai Kumar Reddy,Gopala, Lavanya,Gao, Wei-Wei,Cai, Gui-Xin,Zhou, Cheng-He

, p. 557 - 568 (2018)

A series of natural berberine-derived nitroimidazoles as novel antibacterial agents were designed, synthesized and characterized by nuclear magnetic resonance (NMR), infrared spectra (IR), and high resolution mass spectra (HRMS) spectra. The antimicrobial evaluation showed that some target molecules exhibited moderate to good inhibitory activities against the tested bacteria and fungi including clinical drug-resistant strains isolated from infected patients. Especially, 2-fluorobenzyl derivative 8f not only gave strong activity against drug-resistant E. coli with the minimal inhibitory concentration (MIC) value of 0.003 mM, 33-fold more active than norfloxacin, but also exhibited low toxicity toward RAW 264.7 cells and less propensity to trigger resistance. The aqueous solubility and ClogP values of target compounds were investigated to elucidate the structureactivity relationships. Molecular docking and quantum chemical studies for compound 8f rationally explained its antibacterial effect. The further exploration of antibacterial mechanism revealed that the highly active compound 8f could effectively permeabilize E. coli cell membrane and intercalate into DNA isolated from resistant E. coli to form 8f-DNA complex that might block DNA replication to exert the powerful bioactivities. Compound 8f could also selectively address resistant E. coli from a mixture of various strains.

Synthesis, antioxidant and anticancer screenings of berberine-indole conjugates

Mistry, Bhupendra,Keum, Young-Soo,Kim, Doo Hwan

, p. 3241 - 3256 (2016)

A variety of heterocyclic nitrogen cores in the form of indole moieties were linked to the natural isoquinoline alkaloid molecule berberine to achieve anticipated antioxidant and anticancer properties. An efficient synthetic pathway afforded final compounds 5a-j, which were tested in vitro for antioxidant potency using 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt radical (ABTS) bioassays, and for anticancer activity using sulforhodamine B (SRB) assay against HeLa and Caski cancer cell lines. Moreover, the toxic nature of the resultant molecules was investigated using Madin-Darby canine kidney cells. The therapeutic indices of 5a-j were more appreciable against the Caski than HeLa cell line, in which compounds with electron-releasing alkyl or alkoxy functional group on indole entity as well as azaindole derivative performed well. In addition, these compounds were well endowed with antioxidant properties, in addition to the equal antioxidant effect of the compound with electron-withdrawing chlorine atom within indole entity. Adequate confirmation of the structure of the final analogues was achieved using Fourier-transform infrared (FT-IR), 1H nuclear magnetic resonance (NMR), and mass spectroscopy and elemental (CHN) analysis.

Synthesis and anticancer activity of a novel series of 9-O-substituted berberine derivatives: A lipophilic substitute role

Lo, Chih-Yu,Hsu, Lin-Chen,Chen, Min-Shin,Lin, Yi-Jing,Chen, Lih-Geeng,Kuo, Cheng-Deng,Wu, Jin-Yi

, p. 305 - 309 (2013)

To alter its hydrophobicity, a series of compounds bearing 9-O-alkyl- or 9-O-terpenyl- substituted berberine were synthesized and evaluated for anticancer activity against human cancer HepG2 and HT29 cell lines. We found that the lipophilic substitute of 9-O-alkyl- and 9-O-terpenyl berberine derivatives plays a role in inhibiting the human cancer cell growth and its activity could be maximized with the optimized substitute type and chain length. Most strikingly, nonetheless, of the six compounds prepared, sample 8, a farnesyl 9-O-substituted berberine, showed either comparable or better cytotoxic activity against human cancer HepG2 cell line than that of berberine. Compound 8 had also shown a 104-fold antiproliferation activity in compare with berberine against human hepatoma HepG2 cell lines after 48 incubation hours. Further, in Hoechst 33258 and annexin V-FITC/PI staining analyses it induced apoptosis in HepG2 cells at lower concentration than that of berberine for 24 h. Take all; farnesyl 9-O-substituted berberine could be a potential candidate for new anticancer drug development.

Synthesis, characterization, and biological evaluations of 1,3,5-triazine derivatives of metformin cyclization with berberine and magnolol in the presence of sodium methylate

Cao, Han,Liao, Shili,Zhong, Wenjing,Xiao, Xuerong,Zhu, Jiancheng,Li, Weimin,Wu, Xia,Feng, Yifan

, (2017)

The novel target products were synthesized in the formation of a triazine ring from berberine, magnolol, and metformin catalyzed by sodium methylate. The structures of products 1-3 were firstly confirmed by extensive spectroscopic analyses and single-crystal X-ray diffraction. The crystal structures of the target product 2 and the intermediate product 7b were reported for the first time. All target products were evaluated for their anti-inflammatory and antidiabetic activities against INS-1 and RAW264.1 cells in vitro and all products showed excellent anti-inflammatory effects and anti-insulin resistance effects. Our studies indicated that new compounds 1-3 were found to be active against inflammation and insulin resistance.

ANTIBACTERIAL ACTIVITY OF BEROLINE

Potapova, E. Yu.,Khaidarov, K. Kh.,Sadykov, Yu. D.

, p. 856 - 857 (1988)

-

Experimental and quantum-chemical study of nucleophilic substitution mechanism in berberine

Burov, Oleg N.,Kletskii, Mikhail E.,Fedik, Nikita S.,Kurbatov, Sergey V.,Lisovin, Anton V.

, p. 997 - 1007 (2015)

Principal differences in the interaction mechanisms of alkaloid berberine with primary and secondary amines were investigated experimentally and by quantum-chemical calculations according to density functional theory (DFT/B3LYP) with 6-31G** basis set. The nucleophilic substitution of 9-metoxy group with primary amine was shown to proceed through a stage of σ-complex formation and led to 9-alkylamino derivatives of berberine. Analogous substitution with a secondary amine did not occur due to unfavorable thermodynamic parameters. The secondary amine participated in this reaction not as the attacking nucleophile, but rather as a bifunctional catalyst of berberine hydrolysis to berberrubine. The driving force for all these processes was the stabilization of products by hydrogen bonding. Based on the obtained results, we developed a new effective method for the preparation of berberrubine, one of the key intermediates in synthetic transformations of berberine. New 9-monoalkylamino derivatives of berberine containing indole moieties were synthesized.

Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands

Ma, Yan,Ou, Tian-Miao,Tan, Jia-Heng,Hou, Jin-Qiang,Huang, Shi-Liang,Gu, Lian-Quan,Huang, Zhi-Shu

, p. 3414 - 3417 (2009)

A series of new 9-O-substituted berberine derivatives (4a-j) as telomeric quadruplex ligands was synthesized and evaluated. The results from biophysical and biochemical assay indicated that introducing of positive charged aza-aromatic terminal group into the side chain of 9-position of berberine significantly improved the binding ability with G-quadruplex, and exhibited the inhibitory effect on the hybridization and on telomerase activity. These derivatives showed excellent selectivity for telomeric G-quadruplex DNA over duplex.

Superb-selective chemodosimetric signaling of sulfide in the absence and in the presence of CT-DNA and imaging in living cells by a plant alkaloid berberine analogue

Jana, Gopal Chandra,Khatun, Munira,Nayim, Sk,Das, Somnath,Maji, Anukul,Beg, Maidul,Patra, Anirudha,Bhattacharjee, Paromita,Bhadra, Kakali,Hossain, Maidul

, p. 2368 - 2380 (2019)

The present manuscript reports a lucrative design of a colorimetric and ratiometric chemodosimeter, 9-O-(2,4-dinitrobenzenesulfonyl)berberrubine (BER-S), with excellent water solubility for the superb selective detection of sulfides through a color alteration from yellow to red with a good limit of detection (LOD) of 56 nM in CP buffer solution (10 mM, pH 7.2). Interestingly, this work also includes a smart "turn-on" emission probe (BER-S/DNA complex) showing good linearity with an excellent LOD of 46 nM for recognizing sulfide anions. The probes, BER-S, and BER-S/DNA complex, displayed no interfering effect by other analytes or sulfur-containing inorganic compounds, like thiols. Characterization was carried out using IR, HRMS, and DFT for the BER-S probe, and time-resolved fluorescence lifetime measurement and fluorescence titration for the BER-S/DNA complex probe for elucidating their sensing mechanism. The detection of S2- in waste, tap, and drinking water by BER-S indicated its potential application in real sample analysis, while concentration variant cell imaging experiments (naked-eye red fluorescence) verified its cell-membrane permeability and capability for S2- imaging in living cells. This reaction-based sensing strategy in the presence of DNA may provide a potential platform for the design of a fluorescent chemodosimeter for extensive anion targets.

Synthesis, DNA-binding affinities, and binding mode of berberine dimers

Qin, Yong,Pang, Ji-Yan,Chen, Wen-Hua,Cai, Zongwei,Jiang, Zhi-Hong

, p. 25 - 32 (2006)

Six novel berberine dimers (3a-f) were synthesized in 37-84% yield from the reaction of berberrubine (2) with dihaloalkanes of varying lengths from two to seven carbons. Their interactions with calf thymus (CT) DNA and three double helical oligodeoxynucleotides, d(AAGAATTCTT)2, d(AAGCATGCTT) 2, and d(TAAGAATTCTTA)2, were investigated by means of fluorometric titration and ethidium bromide (EB) displacement experiments. Compared with the monomeric parent berberine (1), these dimers' DNA-binding affinities increased up to approximately 100-fold, suggesting a cooperative interaction of the two berberine subunits in the molecules. Furthermore, these dimers linked by different spacers show a prominent structure-activity relationship when bound with oligodeoxynucleotides. The relative binding affinities are in the order of 3b > 3a > 3c > 3d > 3e > 3f with d(AAGAATTCTT)2 and d(TAAGAATTCTTA)2, and 3b > 3c > 3a > 3d > 3e > 3f with d(AAGCATGCTT)2. Dimer 3b, linked with a propyl chain, exhibits the highest binding affinity. This suggests that a propyl chain may be the most suitable spacer to bridge the two berberine units for DNA binding. Spectrophotometric titration and competitive EB displacement of berberine (1) and dimer 3b indicate that both berberine and its dimers form intercalating complexes with duplex DNA. A larger redshift, a stronger hypochromic effect, and a much higher EB displacement ratio, observed in 3b, indicate that the dimer is in more intimate contact with DNA than berberine. In addition, no obvious binding of canadine (4), a hydrogenated product of berberine, with CT DNA was observed, suggesting critical roles of the quaternary ammonium cation and planar structure in the DNA-binding of berberine.

synthesis and evolution of berberine derivatives as a new class of antiviral agents against enterovirus 71 through the MEK/ERK pathway and autophagy

Wang, Yan-Xiang,Yang, Lu,Wang, Hui-Qiang,Zhao, Xiao-Qiang,Liu, Ting,Li, Ying-Hong,Zeng, Qing-Xuan,Li, Yu-Huan,Song, Dan-Qing

, (2018)

Taking berberine (BBR) as the lead, 23 new BBR derivatives were synthesized and examined for their antiviral activities against four different genotype enterovirus 71 (EV71) strains with a cytopathic effect (CPE) assay. Structure-activity relationship (SAR) studies indicated that introduction of a suitable substituent at the 9-position might be beneficial for potency. Among them, compound 2d exhibited most potent activities with IC50 values of 7.12-14.8 μM, similar to that of BBR. The effect of 2d was further confirmed in a dose-dependent manner both in RNA and protein level. The mechanism revealed that 2d could inhibit the activation of MEK/ERK signaling pathway. Meanwhile, it could suppress the EV71-induced autophagy by activating AKT and inhibiting the phosphorylation of JNK and PI3KIII proteins. We consider BBR derivatives to be a new family of anti-EV71 agents through targeting host components, with an advantage of broad-spectrum anti-EV71 potency.

Synthesis of linked berberine dimers and their remarkably enhanced DNA-binding affinities

Chen, Wen-Hua,Pang, Ji-Yan,Qin, Yong,Peng, Qian,Cai, Zongwei,Jiang, Zhi-Hong

, p. 2689 - 2692 (2005)

This communication describes the facile synthesis of five novel berberine dimers and their strong affinities toward double-stranded DNA. These berberine dimers were synthesized in 37-84% yields from the reaction of berberrubine with dihaloalkanes of varying lengths, and fully characterized by HRMS and 1H NMR. Compared with the monomeric parent berberine, these dimers showed greatly enhanced binding affinities up to approximately 100-fold, with two double helical oligodeoxynucleotides, d(AAGAATTCTT)2 and d(TAAGAATTCTTA)2, which was investigated by means of fluorescence spectrometry.

13-hydroxylation of tetrahydroberberine in cell suspension cultures of some Corydalis species

Iwasa,Kamigauchi

, p. 1511 - 1515 (1996)

Liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry was applied to biotransformation experiments in cultured cells of Corydalis ophiocarpa as well as C. ochotensis var. raddeana. Hydroxylation at C-13 of tetrahydroberberine was shown to take place in cell cultures as well as in C. ophiocarpa plants. N-Methylation of tetrahydroberberine occurred to form the α-N-metho salt incorporating the B/C-cis-quinolizidine system. Introduction of the C-13 methyl with berberine as substrate was confirmed to provide 13-methylberberine. In addition, the reversible oxidation-reduction of the C ring of protoberberines was demonstrated. Copyright

Anti-Inflammation Associated Protective Mechanism of Berberine and its Derivatives on Attenuating Pentylenetetrazole-Induced Seizures in Zebrafish

Zhang, Baoyue,Wang, Lizhen,Ji, Xiuna,Zhang, Shanshan,Sik, Attila,Liu, Kechun,Jin, Meng

, p. 309 - 325 (2020)

Epileptic seizures are characterized by synchronized discharges of neurons, leading to the activation of inflammatory responses that in turn contributes to seizure progression. Berberine (BBR), a bioactive constituent extracted from berberis, has been known to relieve seizures in rodent models. In this study, we synthesized two derivatives of berberine (BBR-D1 and BBR-D2) to compare their seizure reducing effect with BBR in pentylenetetrazole (PTZ)-induced seizures in zebrafish. We found a structure-activity relationship between hydrophilic/hydrophobic composition of the derivatives and their anticonvulsant activity. We also investigated the underlying mechanism related to their anti-inflammatory effect during seizures. BBR and its derivatives increased the seizure onset latency and suppressed the seizure-like behavior after PTZ treatment. Zebrafish larvae pretreated with BBR and its derivatives showed recovery on c-fos expression and neuronal discharges during seizures. The inflammatory responses occurred during the progression of seizures, including the recruitment of macrophages and neutrophils as well as an up-regulation of tumor necrosis factor alpha (TNFα), interleukin 1 beta (il1β), and interleukin 6 (il6). This effect was significantly suppressed by the pretreatment of BBR and its derivatives. Our results suggest that BBR and its derivatives attenuate PTZ-induced seizures and modulate anti-inflammatory effect to potentially protect zebrafish from the occurrence of further seizures. From the tested compounds, BBR-D1 (the hydrophilic berberrubine) showed the strongest seizure reducing effect. [Figure not available: see fulltext.].

Berberine derivatives, preparation method thereof and application of berberine derivatives as p300 HAT small molecule inhibitor

-

Paragraph 0048-0050; 0054-0055; 0066-0070, (2021/02/10)

The invention discloses berberine derivatives, a preparation method thereof and an application of the berberine derivatives as a p300 HAT small molecule inhibitor, and belongs to the technical field of medicinal chemistry. An effective component berberine hydrochloride in a natural product coptis chinensis is taken as a research object and is subjected to structural modification and transformationso as to obtain a series of berberine hydrochloride derivatives. The berberine derivatives have the characteristics of high activity, high selectivity and high safety for p300 HAT, and solves the problems of high cytotoxicity, weak affinity, low activity and poor selectivity of existing p300 HAT small molecule inhibitors.

Novel berberine derivative as well as synthesis method and application thereof

-

Paragraph 0044-0046, (2021/01/29)

The invention discloses a novel berberine derivative as well as a synthesis method and application thereof, belongs to the field of imaging agents, and aims to derive the structure of isoquinoline alkaloid berberine, optimize derived sites on the basis of an early stage and introduce an F-containing side chain to prepare a series of probes with a myocardial targeting property. A 18F marker of theseries of compounds is successfully prepared through a marking experiment of positron nuclide 18F; the 18F-labeled novel berberine derivative is higher in myocardial uptake, raw materials are easy toobtain, the synthesis cost of a molecular probe is reduced, and clinical transformation is facilitated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15401-69-1